Adjunctive steroid treatment in acute bacterial meningitis. "To do or not to do: That is the question"

Acta Clinica Belgica

Volumn 66, Issue 1, 2011, Pages 42-45

  Spapen, Herbert ^a   Van Berlaer, G ^a   Moens, M ^a   Hubloue, I ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Bacterial meningitis; Corticosteroids; Dexamethasone

Indexed keywords

CEPHALOSPORIN; DEXAMETHASONE; PENICILLIN G; PLACEBO; VANCOMYCIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APHASIA; BACTERIAL MENINGITIS; BRAIN HERNIA; CEREBROSPINAL FLUID; CEREBROVASCULAR DISEASE; COMORBIDITY; CONTINUOUS INFUSION; CRANIAL NERVE PARALYSIS; DISEASE SEVERITY; EUROPE; HEART MUSCLE ISCHEMIA; HEMIPARESIS; HUMAN; MORTALITY; MULTICENTER STUDY (TOPIC); NONHUMAN; PNEUMOCOCCAL MENINGITIS; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPTIC SHOCK; STEROID THERAPY; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS SUIS;

EID: 79952614458     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.66.1.2062512     Document Type: Review

References (23)

1. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351: 1849-1859.
2. Feldman WE. Relation of concentration of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis. N Engl J Med 1977; 24: 433-435.
3. Tauber MG, Moser B. Cytokines and chemokinesin meningeal inflammation: biology and clinical implications. Clin Infect Dis 1999; 22: 1-11.
4. Tauber MG, Khayam-Bashi H, Sande MA. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis 1985; 151: 528-534. (Pubitemid 15103807)
5. Mai MTH, Tuan TV, Wolbers M, et al. Immunological and biochemical correlates of adjunctive dexamethasone in Vietnamese adults with bacterial meningitis. Clin Infect Dis 2009; 49: 1387-1392.
6. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med 1988; 319: 964-971.
7. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347: 1549-1556.
8. Weisfelt M, van de Beek D, de Gans J. Dexamethasone treatment in adults with pneumococcal meningitis: risk factors for death. Eur J Clin Microbiol Infect Dis 2006; 25: 73-78. (Pubitemid 43333667)
9. van de Beek D, de Gans J. Dexamethasone and pneumococcal meningitis. Ann Intern Med 2004; 141: 327.
10. Tang BMP, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 2009; 37: 1594-1603.
11. Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009; 301: 2362-2375.
12. Auburtin M, Wolff M, Charpentier J, et al. Detrimental role of delayed antibiotic administration and penicillin - nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: The PNEUMOREA prospective multicenter study. Crit Care Med 2006; 34: 2758-2765. (Pubitemid 44610940)
13. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39: 1267-1284. (Pubitemid 39458512)
14. Cabellos C, Martinez-Lacasa J, Martos A, et al. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob Agents Chemother 1995; 39: 2158-2160.
15. Ahmed A, Jafri H, Lutsar I, et al. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1999; 43: 876-881. (Pubitemid 29165752)
16. Viladrich PF, Gudiol F, Linares J, et al. Evalutation of vancomycin for therapy of adult pneumoccocal meningitis. Antimicrob Agents Chemother 1991; 35: 2467-2472.
17. Ricard JD, Wolff M, Lacherade JC, et al. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis 2007; 44: 250-255. (Pubitemid 46079990)
18. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomized controlled trial. Lancet 2002; 360: 211-218. (Pubitemid 34804649)
19. Scarborough M, Gordon SB, Whitty CJM, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007; 357: 2441-2450. (Pubitemid 350272783)
20. Nguyen TH, Tran TH, Thwaites G, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 2007; 357: 2431-2440. (Pubitemid 350272782)
21. Peltola H, Roine I, Fernandez J, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2007; 45: 1277-1286. (Pubitemid 351411900)
22. Mongelluzzo J, Mohamad Z, Ten Have T, Shah SS. Corticosteroids and mortality in children with bacterial meningitis. JAMA 2008; 299: 2048-2055. (Pubitemid 351656586)
23. Schut ES, Brouwer MC, de Gans J, Florquin S, Troost D, van de Beek D. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis. Neurology 2009; 73: 1988-1995.